Study of Psoriatic Arthritis
Launched by NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) · Nov 3, 1999
Trial Information
Current as of January 13, 2025
Completed
Keywords
ClinConnect Summary
Patients with known or suspected psoriatic arthritis will be evaluated at the Clinical Center. Studies will include characterization of the clinical and laboratory features of the disease, research studies of the natural history and pathogenesis, genetic studies, and determination of the patient's eligibility to enter experimental therapeutic protocols. Patients may be asked to contribute blood, skin or synovial membrane samples for immunologic and genetic research studies.
Gender
ALL
Eligibility criteria
- INCLUSION CRITERIA:
- • Psoriatic arthritis (proven or suspected) or;
- • Family history of psoriasis or psoriatic arthritis (i.e. family members of patients with psoriasis or psoriatic arthritis); and
- • Willingness and ability of the subject or guardian to give informed consent.
- EXCLUSION CRITERIA:
- • Concomitant medical problems which would confound the interpretation of immunological studies.
- • Concomitant medical, surgical or other conditions for which inadequate facilities or funds are available to support their care at the NIH.
About National Institute Of Arthritis And Musculoskeletal And Skin Diseases (Niams)
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a pivotal component of the National Institutes of Health (NIH) dedicated to advancing research and knowledge in the fields of arthritis, musculoskeletal disorders, and skin diseases. NIAMS sponsors a wide range of clinical trials aimed at improving the diagnosis, treatment, and prevention of these conditions. By fostering innovative research, collaborating with healthcare professionals, and engaging with patient communities, NIAMS strives to enhance the quality of life for individuals affected by these diseases, while promoting scientific discovery and public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bethesda, Maryland, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials